Guidance in the Red / Amber List serves ONLY to define where clinical and prescribing responsibility for the listed medicines should lie in terms of governance and safety.
- Inclusion in this list does NOT imply the medicine has been accepted for use via Managed Entry, does NOT imply endorsement of use, and does NOT take account of the cost implications of use of a particular medicine.
- Prescribers should use this list in conjunction with guidance on the Managed entry process for medicines, and the NI formulary which includes information on current cost effective choices.
- As far as possible, new specialist medicines are added to the list at the point when they are granted a UK product licence. In some instances this may be prior to the medicine being launched.
The table below lists specialist medicines. Users should search by generic name where possible. Brand names listed are not exhaustive.
Show All Entries A-B C-D E-J K-M N-R S-Z
| Approved Name | Example Trade Names | Context | Status | Guidance | New Entry |
|---|---|---|---|---|---|
| 5 Aminolaevulinic acid gel | Ameluz | Red | |||
| Abacavir | Red | ||||
| Abacavir with dolutegravir and lamivudine | Triumeq | Red | |||
| Abacavir with lamivudine | Kivexa | Red | |||
| Abacavir with lamivudine and zidovudine | Trizivir | Red | |||
| Abatacept | Orencia | Red | |||
| Abemaciclib | Red | ||||
| Abiraterone | Zytiga | Red | |||
| Abrocitinib | Cibinqo | Red | |||
| Acalabrutinib | Calquence | Red | |||
| Acitretin | Neotigason | Red | |||
| Adalimumab | Humira | Red | |||
| Adefovir | Hepsera | Red | |||
| Afamelanotide | Scenesse | Red | |||
| Afatinib | Tomtovok | Red | |||
| Aflibercept | Eylea, Zaltrap. | Red | |||
| Agomelatine | Valdoxan | Amber status only applies to cover the required monitoring during the first 24 weeks of treatment after which time the arrangement can be stepped down | Amber | Shared Care Guideline in development | |
| Alectinib | Alecensa | Red | |||
| Alemtuzumab | MabCampath, Lemtrada | Red | |||
| Alipogene tiparvovec | Glybera | Red | |||
| Alirocumab | Praluent | Amber | GP Information Sheet | ||
| Alitretinoin | Toctino | Red | |||
| Alpelisib | Red | ||||
| Alprostadil | Caverject, MUSE, Viridal Duo, Vitaros | Erectile dysfunction - severe distress category only | Red | ||
| Ambrisentan | Volibris | Red | |||
| Amifampridine | Firdapse | Red | |||
| Amikacin Inhaled | Arikayce | Red | |||
| Amiodarone | Cordarone X | Amber | Amiodarone Shared Care Guideline | ||
| Amivantamab | Rybrevant | Red | |||
| Anagrelide | Xagrid | Red | |||
| Anakinra | Kineret | Red | |||
| Anti-lymphocyte immunoglobulin (horse) | Atgam | Red | |||
| Antibiotics (IV/parenteral) | Except when for emergency use in doctors’ bags such as Benzylpenicillin or Cefotaxime Or IV antibiotics prescribed as part of a GP Enhanced Service that is supported by Trust Outpatient Parenteral Antibiotic Therapy (OPAT) services or similar services. | Red | |||
| Antiretrovirals | Red | ||||
| Apalutamide | Erleada | Red | |||
| Apomorphine | APO-go | Amber | Apomorphine Shared Care Guideline | ||
| Apremilast | Otezla | Amber | No Shared Care Guideline Required (Click for info) | ||
| Arachis hypogaea | Palforzia | Red | |||
| Argatroban | Exembol | Red | |||
| Arsenic | Trisenox | Red | |||
| Asciminib | Scemblix | Red | |||
| Asfotase alfa | Strensiq | Red | |||
| Ataluren | Translarna | Red | |||
| Atazanavir | Red | ||||
| Atazanavir (with cobicistat) | Evotaz | Red | |||
| Atezolizumab | Tecentriq | Red | |||
| Atomoxetine | Strattera | Amber | Atomoxetine Shared Care Guideline | ||
| Avacopan | Tavneos | Red | |||
| Avalglucosidase alfa | Nexviadyme | Red | |||
| Avanafil | Spedra | Erectile dysfunction - severe distress category only | Red | ||
| Avapritinib | Ayvakit | Red | |||
| Avatrombopag | Doptelet | Red | |||
| Avelumab | Bavencio | Red | |||
| Axicabtagene ciloleucel | Red | ||||
| Axitinib | Inlyta | Red | |||
| Azacitadine | Vidaza | Red | |||
| Azathioprine | Imuran | Non transplant indications | Amber | Azathioprine (Other Non-Transplant Indications) Shared Care Guideline | |
| Azathioprine | Imuran | Immunosuppressant post transplantation | Amber | Azathioprine Post Transplant Shared Care Guideline | |
| Aztreonam (Inhaled) | Cayston | Inhaled for chronic pulmonary infections | Red | ||
| Baricitinib | Olumiant | Red | |||
| Bedaquiline | Sirturo | Red | |||
| Belantamab mafodotin | Blenrep | Red | |||
| Belimumab | Benlysta | Red | |||
| Belzutifan | Welireg | Red | |||
| Benralizumab | Red | ||||
| Berotralstat | Orladeyo | Red | |||
| Betaine | Cystadane | Amber | GP Information sheet | ||
| Bevacizumab | Avastin | Red | |||
| Bexarotene | Targretin | Red | |||
| Bezlotoxumab | Zinplava | Red | |||
| Bicalutamide | Casodex | Amber | No Shared Care Guideline Required (Click for info) | ||
| Bictegravir + emtricitabine + tenofovir alafenamide | Biktarvy | Red | |||
| Bimekizumab | Bimzelx | Red | |||
| Binimetinib | Red | ||||
| Blinatumomab | Blincyto | Red | |||
| Boceprevir | Victrelis | Red | |||
| Bortezomib | Velcade | Red | |||
| Bosentan | Tracleer | Red | |||
| Bosutinib | Bosulif | Red | |||
| Botulinum toxin type A and B | various brands | For all uses except cosmetic | Red | ||
| Brentuximab | Adcetris | Red | |||
| Brigatinib | Alunbrig | Red | |||
| Brodalumab | Kyntheum | Red | |||
| Bromelain | Nexobrid | Red | |||
| Burosumab | Crysvita | Red | |||
| Buserelin | Suprecur, Suprefact | When used for treatment of infertility | Red | ||
| Busulfan | Myleran | Red |